Release Date: 14/11/11 17:01 Summary: Unaudited Interim Financial Report Price Sensitive: No Download Document 79.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%